• 1
    The Consensus Trial Study GroupEffects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandanavian Enalapril Survival StudyNew Engl J Med198731614291435
  • 2
    The SOLVD InvestigatorsEffect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failureNew Engl J Med1991325292302
  • 3
    GlickH.CookJ.KinosianB. et al. Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) treatment trialJ Cardiac Failure19951371380
  • 4
    The Task Force of the Working Group on Heart Failure of the European Society of CardiologyThe treatment of heart failureEur Heart J199718736753
  • 5
    EcclesM.FreemantleN.MasonJ.North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failureBr Med J199831613691375
  • 6
    Advisory Council to Improve Outcomes Nationwide in Heart FailureConsensus recommendations for heart failureAm J Cardiol199983Suppl 2A1A38
  • 7
    PackerM.Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?J Am College Cardiol199633316701676
  • 8
    ClelandJ.G.Poole-WilsonP.A.ACE inhibitors for heart failure: a question of doseBr Heart J199472Suppl 3S106S110
  • 9
    PackerM.Poole-WilsonP.A.ArmstrongP.W. et al. Comparative effects of low doses and high doses of the angiotensin converting-enzyme inhibitor, lisinopril, on mortbidity and mortality in chronic heart failureCirculation199910023122318
  • 10
    The Chartered Institute of Public Finance and Accountancy (CIPFA)The Health Service Database 19981998CroydonCIPFA
  • 11
    British National Formulary, Number 361998LondonBritish Medical Association and the Royal Pharmaceutical Society of Great Britain
  • 12
    NettenA.DennettJ.KnightJ.Unit Costs of Health and Social Care1998CanterburyPSSRU, University of Kent
  • 13
    LinD.Y.FeuerE.J.EtzioniR.WaxY.Estimating medical costs from incomplete follow-up dataBiometrics199753419434
  • 14
    BriggsA.GrayA.The distribution of health care costs and their statistical analysis for economic evaluationJ Health Services Res Policy19983233245
  • 15
    Department of HealthPolicy Appraisal and Health1995LondonDepartment of Health
  • 16
    Van HoutB.A.AlM.J.GordonG.S.RuttenF.F.H.Costs, effects and c/e-ratios alongside a clinical trialHealth Econ19943309319
  • 17
    UK Prospective Diabetes Study GroupCost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40Br Med J1998317720726
  • 18
    BriggsA.H.A Bayesian approach to stochastic cost-effectiveness analysisHealth Econ19998257262
  • 19
    GoldM.R.SiegelJ.E.RussellL.B.WeinsteinM.C.Cost-effectiveness analysis in health and medicine1996New YorkOxford University Press
  • 20
    North of England Evidence Based Guideline Development Project. ACE Inhibitors in the Primary Care Management of Adults with Symptomatic Heart Failure1998Newcastle upon TyneCentre for Health Services Research, University of Newcastle upon Tyne
  • 21
    LaupacisA.FeenyD.DetskyA.S.TugwellP.X.How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluationsCan Med Assoc J1992146473481
  • 22
    Department of HealthRegister of cost-effectiveness studies1994LondonDepartment of Health, Economics and Operational Research Division
  • 23
    McGlynnE.A.NaylorD.AndersonG.M. et al. Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York stateJ Am Med Assoc1994272934941